Recovering Hearts. Saving Lives.
Abiomed (NASDAQ: ABMD) is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow and/or temporarily assisting with the pumping function of the heart. The Abiomed Breethe OXY-1 System™ is designed to provide oxygenation while supporting patient mobility.
Abiomed's board of directors and management team set our strategic direction. Learn more about our senior leadership.
Abiomed’s Four Principles
Recovering Hearts & Saving Lives
Recovering hearts and saving lives is the founding principle and guiding compass of our organization. This is our highest recognition of success. Recovering and preserving our patients’ hearts and oxygenating their bodies enables them to return home to their families and enjoy an improved quality of life.
Leading in Technology & Innovation
We are committed to providing patients and health care providers with the highest quality devices and optimal cost-effective solutions. We accomplish this through the relentless exploration of new ideas and approaches that allow us to address new clinical challenges for our customers and patients.
Growing Shareholder Value
Growing shareholder value rewards our investors and helps to ensure the company’s financial stability, allowing for the continued pursuit of our mission. Shareholder value is driven by executing our goals and achieving positive financial results. For employees, growth of shareholder value provides financial security for our families and the pursuit of happiness for our future.
Sustaining a Winning Culture
Patients First. Our patients and customers are the motivation for all that we do and achieving our mission is dependent on their well-being. We must always act with integrity and honor and demand the best of ourselves. We work hard, have faith in each other, and have fun celebrating the patient success stories.
Commitment to Research
Abiomed invests in clinical research to provide the best possible outcomes for our patients.
Through relentless innovation, we develop smaller, smarter, and more connected technology.
Abiomed was founded in 1981 for the purpose of developing the world's first artificial heart. Explore this interactive timeline that shows how Abiomed’s mission evolved to focus on native heart recovery. Through its history, Abiomed has been dedicated to bringing the most advanced and innovative technology to patients and physicians.
We sustain a winning culture by putting patients first. We work collaboratively to foster a spirit of innovation. Our employees bring diverse ideas and experiences.